Medication info
Telmisartan 80 mg Tablets (Telmisartan)

Telmisartan 80 mg Tablets (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tablet
Manufacturer / importer
Hana Pharmaceutical Co., Ltd.
Appearance
White or off-white, convex oval tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201501714 · Approved 2015.03.31 · Insurance code 657805540

Summary

Main use
Treatment of essential hypertension and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Administer telmisartan 40 mg orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Following initiation of treatment, the maximum blood pressure-lowering effect is achieved in 4 ∼ 8 weeks. When this medicine is administered in combination with a thiazide diuretic such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. 2. Reduction of cardiovascular risk Adults: It is recommended to administer 80 mg of this medicine orally once daily with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Hana Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • clinical evidence of high-risk diabetes with organ damage
  • myocardial infarction
View approved original text

This medication stabilizes blood pressure in patients with essential hypertension, helping with blood pressure management. It is also used to reduce the risk of myocardial infarction, stroke, and mortality due to cardiovascular diseases in patients aged 55 and older who are at high risk for conditions such as coronary artery disease, peripheral artery disease, and stroke. Through these actions, it effectively improves cardiovascular health for patients.

How to take

Adult dose

1. Essential hypertension Adults: Administer telmisartan 40 mg orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. Following initiation of treatment, the maximum blood pressure-lowering effect is achieved in 4 ∼ 8 weeks. When this medicine is administered in combination with a thiazide diuretic such as hydrochlorothiazide, an additional blood pressure-lowering effect is observed. 2. Reduction of cardiovascular risk Adults: It is recommended to administer 80 mg of this medicine orally once daily with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When initiating treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can pose serious risks, especially to the fetus and newborn during pregnancy, so it should be discontinued immediately if pregnancy is confirmed. It should not be administered to women with an allergic reaction to this medication, pregnant or breastfeeding women, patients with severe liver impairment or biliary obstruction, patients with certain hereditary angioedema, or patients with diabetes or severe renal impairment. Caution is advised when using this medication in elderly patients or those with hyperkalemia, mild to moderate liver impairment, heart valve diseases, gastrointestinal diseases, renal artery hypertension, or severe renal impairment. Various adverse reactions may occur during treatment, so the patient's condition should be closely monitored, especially for symptoms such as hypotension, worsening renal function, hyperkalemia, angioedema, hepatic dysfunction, interstitial pneumonia, and rhabdomyolysis. Patients with impaired renal function or who have received kidney transplants should have their serum potassium and creatinine levels checked regularly, and patients with hypovolemia or sodium deficiency may be at risk for hypotension; thus, corrections should be made before administration. Care should be taken when used with other drugs that increase antihypertensive effects, especially with other RAAS acting drugs, potassium-sparing diuretics, and NSAIDs, as there is a higher risk of worsening renal function or hyperkalemia. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women should also avoid its use. Safety and efficacy in children under 18 years have not been established, so its use is not recommended. In elderly patients, there is a risk of excessive blood pressure reduction leading to stroke, so administration should be done with caution. In cases of overdose, symptoms such as hypotension, dizziness, and acute renal failure may occur, so immediate medical attention is required, and blood pressure and electrolyte status should be monitored regularly. It is best to store this medication in a tightly sealed container, out of reach of children, and avoid transferring it to other containers. Caution is needed while driving or operating dangerous machinery as dizziness or fainting may occur.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 98 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbances
  • liver function abnormalities
  • liver dysfunction
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • low back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • hunger
  • cold sweat
  • hand tremor
  • decreased concentration
  • convulsions
  • altered consciousness
  • facial swelling
  • lip swelling
  • pharyngeal and laryngeal swelling
  • tongue swelling
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • jaundice
  • dyspnea
  • hypotension
  • laryngeal edema
  • fever
  • pneumonia
  • myalgia
  • increased creatine kinase
  • increased serum myoglobin
  • elevated urinary myoglobin
  • palpitations
  • fatigue
  • nausea
  • insufficient effect
  • headache
  • dizziness
  • cough
  • dyspepsia
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • petechiae
  • arrhythmia
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and kept at room temperature between 1 and 30 degrees Celsius for safety. This way, the effectiveness of the medication can be well maintained.

Appearance and packaging

Appearance

White or off-white, convex oval tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.